It will grow to $2566.4 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%
The Tumor Necrosis Factor Inhibitor Drugs by The Business Research Company provides market overview across 60+ geographies in the seven…
New product launches, a robust pipeline, an increase in the frequency of autoimmune diseases, and a significant increase in consumer…